Joie Armstrong asked her doctor about taking a GLP-1 medication to help her lose weight six times before she got a prescription, and then was denied coverage by her insurance company. Adrian, a ...

Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough to interfere with daily activities. Despite a multitude of treatment ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...

Dr. Ambish Mithal unpacks the world of new-age weight management drugs, their side effects, their benefits and what lies ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a new study after hundreds of cases of acute and ...

The weight loss and diabetes drug, which is only available on prescription, should be on pharmacy shelves within days ending ...

So-called ‘skinny jabs’ are being prescribed to people who don’t need them, with terrifying side effects. How did our ...

The government issued a serious warning relating to sexual health for Mounjaro users. And tomorrow (23 June), the weight loss ...